MX2020004073A - Procesos de siembra en serie y usos de los mismos. - Google Patents

Procesos de siembra en serie y usos de los mismos.

Info

Publication number
MX2020004073A
MX2020004073A MX2020004073A MX2020004073A MX2020004073A MX 2020004073 A MX2020004073 A MX 2020004073A MX 2020004073 A MX2020004073 A MX 2020004073A MX 2020004073 A MX2020004073 A MX 2020004073A MX 2020004073 A MX2020004073 A MX 2020004073A
Authority
MX
Mexico
Prior art keywords
seed train
train processes
processes
seed
producing
Prior art date
Application number
MX2020004073A
Other languages
English (en)
Inventor
Weichang Zhou
Benjamin Wright
Konstantin Konstantinov
Michael Bruninghaus
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53477008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020004073(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2020004073A publication Critical patent/MX2020004073A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/28—Constructional details, e.g. recesses, hinges disposable or single use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/58—Reaction vessels connected in series or in parallel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16—Vibrating; Shaking; Tilting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

En la presente invención se proporcionan en la presente procesos de siembra en serie y métodos para producir una proteína recombinante que incluye el uso de estos procesos de siembre en serie.
MX2020004073A 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos. MX2020004073A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462009553P 2014-06-09 2014-06-09

Publications (1)

Publication Number Publication Date
MX2020004073A true MX2020004073A (es) 2020-07-29

Family

ID=53477008

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016016301A MX373323B (es) 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos.
MX2020004073A MX2020004073A (es) 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016016301A MX373323B (es) 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos.

Country Status (18)

Country Link
US (2) US10570367B2 (es)
EP (3) EP3152299B1 (es)
JP (3) JP6784600B2 (es)
KR (2) KR102584375B1 (es)
CN (2) CN106574249B (es)
AU (3) AU2015274897B2 (es)
BR (1) BR112016028891B1 (es)
CA (1) CA2951551C (es)
CY (1) CY1122803T1 (es)
DK (1) DK3152299T3 (es)
ES (2) ES3043610T3 (es)
HU (1) HUE047683T2 (es)
IL (3) IL290096B2 (es)
MX (2) MX373323B (es)
RU (1) RU2694327C2 (es)
SG (1) SG11201610216UA (es)
TW (3) TWI707949B (es)
WO (1) WO2015191462A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014130872A2 (en) 2013-02-22 2014-08-28 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
ES2717927T3 (es) 2013-02-22 2019-06-26 Genzyme Corp Procedimientos de cultivo por perfusión de microportadores y usos de los mismos
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
CA3225136A1 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell
WO2017072201A2 (en) * 2015-10-26 2017-05-04 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
WO2018116967A1 (ja) * 2016-12-22 2018-06-28 東亞合成株式会社 接着剤組成物並びにこれを用いたカバーレイフィルム、ボンディングシート、銅張積層板及び電磁波シールド材
JP2020533983A (ja) * 2017-09-15 2020-11-26 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 目的のポリペプチドのラージスケールの製造間のオンラインバイオマス静電容量モニタリング
TWI846694B (zh) 2018-05-04 2024-07-01 美商健臻公司 具有過濾系統的灌注式生物反應器
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
EP3650528A1 (en) 2018-11-08 2020-05-13 Aglaris Ltd Cell culture system and method
KR102750136B1 (ko) * 2019-01-25 2025-01-03 엔진 바이오사이언스 리미티드 치료 단백질 생산을 위한 자동화 통합 연속 시스템 및 바이오 공정
EP3924458A1 (en) * 2019-02-15 2021-12-22 Just-Evotec Biologics, Inc. Automated biomanufacturing systems, facilities, and processes
US20200370016A1 (en) * 2019-05-24 2020-11-26 Rubius Therapeutics, Inc. Methods of generating enucleated erythroid cells
GB2622972B (en) * 2019-06-17 2024-09-18 Deka Products Lp System and method for cell and tissue preparation
GB201908612D0 (en) * 2019-06-17 2019-07-31 Ge Healthcare Bio Sciences Ab A method for separating biomolecules
EP4008774A4 (en) * 2019-07-16 2023-09-27 Innovent Biologics (Suzhou) Co., Ltd. CELL CULTURE METHOD AND ITS APPLICATION BASED ON CONTINUOUS AND HIGH DENSITY INOCULATION
EP3831924A1 (en) * 2019-12-03 2021-06-09 Sartorius Stedim Data Analytics AB Adapting control of a cell culture in a production scale vessel with regard to a starting medium
CA3257876A1 (en) * 2022-06-28 2024-01-04 Amgen Inc. ADAPTIVE FACILITY CONFIGURATIONS FOR THE MANUFACTURING THERAPEUTIC PRODUCTS
JP2025527931A (ja) * 2022-09-06 2025-08-22 アムジェン インコーポレイテッド 大規模バイオリアクタシステム及び方法
CN120882853A (zh) * 2023-03-13 2025-10-31 美国安进公司 用于种子制备优化的系统和方法
WO2026033566A2 (en) 2024-08-09 2026-02-12 Omnibrx Biotechnologies Private Limited A multistage bioreactor system and method thereof
GB202414239D0 (en) * 2024-09-27 2024-11-13 St Andrews Pharmaceutical Tech Limited Method and/or apparatus for producing a cell inoculum for use in a biomanufacturing or cell culture process

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2058992C1 (ru) 1993-07-14 1996-04-27 Антипин Георгий Васильевич Способ получения кормового белка и устройство для его осуществления
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
RU2215748C2 (ru) 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
JP4176472B2 (ja) * 2000-12-20 2008-11-05 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞の種連続増殖（ｓｅｅｄ−ｔｒａｉｎｅｘｐａｎｓｉｏｎ）のための装置及び方法
JP2005509406A (ja) 2001-05-09 2005-04-14 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞株のための低温保存袋アセンブリー
PT1451290E (pt) 2001-08-31 2011-03-09 Bayer Schering Pharma Ag Uma unidade e um processo para levar a cabo a fermentação com elevada densidade celular
HUP0402158A2 (hu) 2001-10-02 2005-01-28 Novo Nordisk Health Care Ag Rekombináns fehérjék előállítási eljárása eukarióta sejtekben
WO2003039459A2 (en) 2001-11-05 2003-05-15 Genvec, Inc. Viral vector production methods and compositions
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US20050019914A1 (en) * 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
US20050186669A1 (en) 2004-02-20 2005-08-25 Cesco Bioengineering Co., Ltd. Apparatus and method for preparing and culturing cells
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
JP4914835B2 (ja) 2004-09-16 2012-04-11 ベクトン・ディキンソン・アンド・カンパニー 細胞培養用の潅流バイオリアクタ
DK1807101T3 (en) 2004-09-30 2016-05-23 Bayer Healthcare Llc Devices and methods for integrated continuous production of biological molecules
WO2006138143A1 (en) 2005-06-15 2006-12-28 Amprotein Corporation Suspension culture vessels
ES2662589T3 (es) 2005-06-15 2018-04-09 Zhejiang Jinyishengshi Bioengineering Co., Ltd. Recipientes para cultivo en suspensión
US20080206819A1 (en) 2006-08-21 2008-08-28 Mary Tsao Intensified Perfusion Production Method
US20080207487A1 (en) 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
WO2008106515A1 (en) 2007-02-27 2008-09-04 The Board Of Trustees Of The University Of Illinois Insert device for multiwell plate
JP5467415B2 (ja) * 2007-03-02 2014-04-09 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト タンパク質製造の改良
CN101678244B (zh) 2007-04-17 2013-06-19 深度控股有限公司 用于连续膜吸附的方法和装置
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
EP2188371B1 (en) 2007-08-09 2017-12-20 Wyeth LLC Use of perfusion to enhance production of fed-batch cell culture in bioreactors
WO2009034186A2 (en) 2007-09-13 2009-03-19 Helmholtz-Zentrum für Infektionsforschung GmbH Process for cell cultivation
US20090233334A1 (en) 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
DE102008019691A1 (de) 2008-04-15 2009-10-29 Technische Universität Ilmenau Teilaktives mikrofluidisches System für die 3D-Zellkultivierung sowie Verfahren zu dessen Perfusion
US20100076380A1 (en) 2008-06-16 2010-03-25 Amprotein Corporation Bioreactors
US8728479B2 (en) 2009-03-31 2014-05-20 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
JP2012531930A (ja) 2009-07-06 2012-12-13 ジェネンテック， インコーポレイテッド 真核生物細胞の培養方法
JP2013544524A (ja) * 2010-12-06 2013-12-19 ターポン バイオシステムズ，インコーポレイテッド 生物学的生成物の連続プロセス法
SG191745A1 (en) 2011-01-17 2013-08-30 Hoffmann La Roche Separation apparatus and use thereof
AU2012252305B2 (en) 2011-05-12 2017-02-02 Probiogen Ag Enhancement of protein production yield mediated by a fast shuttling cdc42 gtpase
KR101662412B1 (ko) 2011-07-01 2016-10-04 암젠 인크 포유동물 세포 배양
AR089231A1 (es) * 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
US20150004686A1 (en) 2012-02-02 2015-01-01 Corning Incorporated Automatic continuous perfusion cell culture microplate consumables
SG10201607963SA (en) 2012-04-01 2016-11-29 Emd Millipore Corp Cell culture and gradient migration assay method and devices
AU2013334602B2 (en) 2012-10-23 2018-05-31 Genzyme Corporation Perfusion culturing methods and uses thereof
ES2717927T3 (es) 2013-02-22 2019-06-26 Genzyme Corp Procedimientos de cultivo por perfusión de microportadores y usos de los mismos
WO2014130872A2 (en) 2013-02-22 2014-08-28 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
CN118388581A (zh) 2013-03-08 2024-07-26 建新公司 治疗性蛋白药物物质的整合连续制造
JP6742902B2 (ja) 2013-03-15 2020-08-19 ジェンザイム・コーポレーション 高密度細胞バンキングの方法
KR20230142653A (ko) 2013-09-16 2023-10-11 젠자임 코포레이션 세포 배양물을 가공하는 방법 및 시스템
JP2017500017A (ja) * 2013-12-20 2017-01-05 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 生物薬剤フェドバッチ生産能力及び生産物品質を改善するための灌流シード培養の使用
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
SG10202113019XA (en) 2014-06-04 2021-12-30 Amgen Inc Methods for harvesting mammalian cell cultures
TW202204596A (zh) * 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI707949B (zh) 2014-06-09 2020-10-21 美商健臻公司 種子罐培養法（ｓｅｅｄ ｔｒａｉｎ ｐｒｏｃｅｓｓｅｓ）及其用途
CN104450597B (zh) 2014-12-10 2020-07-28 青岛农业大学 一种石油降解菌固体菌剂的制备方法及由其制备的固体菌剂修复石油污染的土壤的方法
CA3225136A1 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell

Also Published As

Publication number Publication date
CN111575225B (zh) 2023-09-08
ES3043610T3 (en) 2025-11-25
RU2019119708A (ru) 2019-07-03
IL290096B2 (en) 2024-04-01
JP2022120031A (ja) 2022-08-17
KR102416402B1 (ko) 2022-07-04
IL281626B (en) 2022-03-01
CN111575225A (zh) 2020-08-25
AU2015274897B2 (en) 2021-11-04
IL249452A0 (en) 2017-02-28
MX2016016301A (es) 2017-04-06
JP2021019621A (ja) 2021-02-18
EP3858983C0 (en) 2025-07-16
EP3858983B1 (en) 2025-07-16
CA2951551C (en) 2023-02-28
RU2694327C2 (ru) 2019-07-11
JP2017521057A (ja) 2017-08-03
EP3858983A1 (en) 2021-08-04
US10570367B2 (en) 2020-02-25
RU2016151316A3 (es) 2018-11-15
CA2951551A1 (en) 2015-12-17
CN106574249B (zh) 2020-05-08
SG11201610216UA (en) 2017-01-27
TW202246486A (zh) 2022-12-01
US20150353896A1 (en) 2015-12-10
TWI707949B (zh) 2020-10-21
AU2021245116A1 (en) 2021-10-28
TW202102658A (zh) 2021-01-16
AU2015274897A1 (en) 2017-01-12
BR112016028891A2 (pt) 2017-08-22
MX373323B (es) 2020-05-04
AU2021245116B2 (en) 2023-07-27
TW201610148A (zh) 2016-03-16
JP7089000B2 (ja) 2022-06-21
ES2773630T3 (es) 2020-07-13
KR20170015472A (ko) 2017-02-08
AU2023203734A1 (en) 2023-07-06
EP3152299A1 (en) 2017-04-12
EP3628730A1 (en) 2020-04-01
US20200377850A1 (en) 2020-12-03
RU2016151316A (ru) 2018-07-10
KR20220098051A (ko) 2022-07-08
IL249452B (en) 2021-04-29
KR102584375B1 (ko) 2023-09-27
EP3152299B1 (en) 2019-11-20
IL290096B1 (en) 2023-12-01
DK3152299T3 (da) 2020-02-24
HUE047683T2 (hu) 2020-05-28
JP7360504B2 (ja) 2023-10-12
IL290096A (en) 2022-03-01
CY1122803T1 (el) 2021-05-05
CN106574249A (zh) 2017-04-19
TWI776235B (zh) 2022-09-01
BR112016028891B1 (pt) 2023-04-11
WO2015191462A1 (en) 2015-12-17
IL281626A (en) 2021-05-31
JP6784600B2 (ja) 2020-11-11

Similar Documents

Publication Publication Date Title
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
IL290096A (en) Processes for the insemination series and their uses
PH12017500877B1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
MX2021010418A (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
MX2022003273A (es) Anticuerpos anti-tau y metodos de uso.
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MY193661A (en) Anti-tim3 antibodies and methods of use
PH12017500322A1 (en) Anti-her2 antibodies and immunoconjugates
MX2016015162A (es) Anticuerpos anti - gpc3 e inmunoconjugados.
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
PH12016501763A1 (en) Multispecific antibodies
EP3104865A4 (en) Micro-organoids, and methods of making and using the same
IN2015DE00625A (es)
MX2017005975A (es) Anticuerpos anti factor de crecimiento derivado de plaquetas b (pdgf-b) y metodos de uso.
IL250451A0 (en) Anti-vasa antibodies, and methods for their preparation and use
MY167350A (en) Fat-and-oil composition and chocolate
AU359863S (en) Endoscope system workstation
AU360519S (en) Wire grippers
EP3125685A4 (en) Producing therapeutic proteins
NZ744340A (en) Anti-jagged1 antibodies and methods of use
AU365961S (en) Clasp
AU366976S (en) Lighter
MX2018001296A (es) Proceso para la sintesis de ravidasvir.
AU358216S (en) A flexible gemstone setting
AU359887S (en) Rebalancing apparatus for the human body